GeoVax Labs price to sales ratio GOVX

Market value divided by revenue over the last twelve months, since 2019.

Today, Oct 23, 2026: n/m; not in our data today
Last meaningful: 3.0×; Jul 2026
8-year median: 4.8×
8-year range: 0.0× to 155×
Peer median: 0.4×

GeoVax Labs has no meaningful price to sales ratio today: it is not in our data for Oct 23, 2026.

It was last meaningful in Jul 2026, at 3.0×.

On the days it had one over the last 8 years, its median was 4.8×, from 0.0× in Oct 2019 to 155× in Aug 2022.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	3.0×	0.4×	14.8×
2025	1.6×	1.3×	4.0×
2024	n/m a value too high to mean anything
2023	66.3×	66.3×	99.9×
2022	67.3×	16.4×	155×
2021	48.9×	6.8×	63.4×
2020	7.0×	0.0×	9.2×
2019	0.1×	0.0×	2.5×

Against its peers

Companies in Healthcare nearest GeoVax Labs' size, closest first, today.

Company	Price to sales ratio
GOVXGeoVax Labs	n/m
OXBROXBRIDGE RE HOLDINGS	2.8×
EDUCEducational Development	0.4×
GTIMGood Times Restaurants	0.1×
Peer median	0.4×

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on GeoVax Labs

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.